SBI Term Loan: RLLR: 8.15 | 7.25% - 8.55%
Canara Bank: RLLR: 8 | 7.15% - 9.85%
ICICI Bank: RLLR: -- | 8.5% - 9.65%
Punjab & Sind Bank: RLLR: 7.3 | 7.35% - 10.75%
Bank of Baroda: RLLR: 7.9 | 7.2% - 8.95%
Federal Bank: RLLR: -- | 7.35% - 9.6%
IndusInd Bank: RLLR: -- | 7.6% - 10%
Bank of Maharashtra: RLLR: 8.05 | 7% - 9.15%
Yes Bank: RLLR: -- | 7.4% - 10.54%
Karur Vysya Bank: RLLR: 8.8 | 8.5% - 10.65%
HDFC Bank: RLLR: -- | 7.75% - 13.2%
Axis Bank: RLLR: -- | 8% - 9.1%
IDBI Bank: RLLR: -- | 7.4% - 10%

Indian shares fall as Middle East tensions, US rate-hike bets weigh on properties and markets

#Economy#India
Synopsis

Indian equity markets extended their recent decline on Monday as renewed Middle East tensions, higher crude oil prices and stronger-than-expected US jobs data weighed on investor sentiment. The possibility of a US Federal Reserve rate hike this month puts additional pressure on technology stocks, which have high exposure to the US market. The Nifty 50 and Sensex both ended 0.5% lower, while IT and media stocks were among the major losers. Company-specific developments at Zee Entertainment, Indoco Remedies and PVR Inox also contributed to sharp moves in individual stocks.

Indian shares fell on Monday, extending a losing streak that has now stretched across five consecutive weeks, as investors reacted to rising geopolitical tensions in the Middle East and growing expectations of a US interest rate hike. The Nifty 50 ended 0.5% lower at 23,779.15, while the BSE Sensex declined 0.5% to 76,132.81. Both benchmarks closed at their lowest levels in about six weeks. 
The decline was broad-based, with 14 of the 16 major sectoral indices ending lower. The Nifty IT index was among the biggest drags, falling about 2.3%, as stronger-than-expected US employment data increased expectations that the Federal Reserve could raise interest rates at its upcoming policy meeting. 
Higher US interest rates could put pressure on spending by American clients, which could affect Indian IT companies that earn a large portion of their revenue from the US market. The weakness in IT stocks therefore reflected concerns over both global interest rates and the outlook for technology spending. 
Mid-cap and small-cap stocks also remained under pressure. The Nifty Midcap 100 fell about 0.5%, while the Nifty Smallcap 100 was broadly flat by the close. Rising crude oil prices and the escalation of tensions involving the US and Iran added to concerns around inflation and overall risk appetite. 
Brent crude was trading close to USD 97 a barrel during the session, adding another concern for India, which remains heavily dependent on imported crude oil. Higher oil prices can increase the country's import bill and add pressure to inflation, corporate costs and the broader macroeconomic outlook. 
Market participants are also watching upcoming US inflation data closely, as it could influence expectations ahead of the Federal Reserve's policy meeting scheduled for September 16. Analysts said renewed tensions between the US and Iran could push crude prices higher, while a heavy pipeline of initial public offerings could absorb liquidity that might otherwise flow into the secondary market. 
The latest decline extends a broader period of weakness. The Nifty and Sensex have fallen about 2.7% and 2.5%, respectively, over the past four weeks as higher oil prices and global bond yields have weighed on Indian equities. 
Zee Entertainment fell sharply after the Central Bureau of Investigation registered a case against Essel Group chairman and Zee founder Subhash Chandra and others over alleged fraud involving loans of more than INR 1,322 crore from LIC Housing Finance. The case relates to allegations that inflated net-worth documents were used to obtain loans, which later went into default. 
The development comes amid continuing legal and financial scrutiny surrounding Chandra. The National Company Law Tribunal had recently stayed an earlier order approving his INR 6.5-crore repayment plan against admitted claims of around INR 22,006 crore. The matter remains under consideration, with creditor objections still pending. 
Indoco Remedies declined after the US Food and Drug Administration completed an inspection of the company's Plant II sterile manufacturing facility in Goa and issued seven observations in Form 483. The inspection had taken place from August 27 to September 4. The company said it was addressing the observations and would respond to the US regulator within the stipulated timeframe. 
The regulatory development came despite an improvement in Indoco Remedies' recent financial performance. Its consolidated net profit stood at INR 64.99 crore in the first quarter of FY27, compared with a net loss of INR 35.79 crore in the year-earlier period, while revenue from operations increased 8.43% year-on-year to INR 466.22 crore. 
PVR Inox was another major decliner, falling as much as 8% during Monday's trading session after reports emerged about an internal investigation into alleged kickbacks involving developers working on cinema properties. The reports said a senior executive, Pramod Arora, was asked to leave in April following the investigation and that the alleged payments could total up to INR 200 crore. 
However, PVR Inox subsequently said its preliminary internal investigation into anonymous allegations of misconduct found no evidence of kickbacks. The company also disputed aspects of reports concerning the circumstances surrounding the executive's departure. 
PVR Inox was formed through the merger of PVR and INOX Leisure, which became effective in 2023. Arora had been involved in the company's growth and investment activities, including expansion into smaller cities through asset-light cinema formats. 
Source Reuters

Discussion

Have something to say? Post your comment